The Prevalence of Some Epidemic Leishmania Spp. Isolated from Human Blood and Skin Samples
Keywords:
Cutaneous leishmaniasis , Epidemic Leishmania , Leishmaniasis , Visceral leishmaniasisAbstract
Leishmaniasis ranks as the second deadliest parasitic disease globally, following malaria. Recognized by the World Health Organization as a neglected tropical disease, leishmaniasis continues to pose a major public health challenge. This study aimed to evaluate the sensitivity and specificity of the Direct Agglutination Test as a diagnostic tool for leishmaniasis. A total of 666 dried blood samples were collected between March 7 and June 21, 2024. These included 606 samples from suspected visceral leishmaniasis cases, 63 from cutaneous leishmaniasis cases, 66 from healthy individuals as controls, and 63 from individuals with other medical conditions. The study focused on three main objectives: evaluating the Direct Agglutination Test using locally prepared Leishmania antigens (L. donovani, L. tropica, and L. major), identifying sandfly species, and monitoring their seasonal population densities. The Leishmania antigens were prepared using mercapto-ethanol and glutaraldehyde. The direct agglutination test demonstrated 100% sensitivity in confirmed cases of visceral leishmaniasis when using the L. donovani antigen, and 93% sensitivity in clinically suspected cases. For cutaneous leishmaniasis, the L. tropica antigen also achieved 100% sensitivity. In contrast, traditional diagnostic methods—such as smears and cultures—yielded lower positivity rates, at 60.16% and 69.46% respectively. Among the antigens tested, L. tropica showed the highest specificity at 96.19%, followed by L. donovani at 87.68%. Cross-reactivity with sera from individuals with other diseases was minimal. Visceral leishmaniasis was most prevalent among children under five years old, while cutaneous cases were more common in the 6–30 age group. Males were more frequently affected in both forms of the disease. Visceral leishmaniasis cases were predominantly reported in rural areas, whereas cutaneous cases were more common in urban settings. Most cutaneous lesions (96.6%) were single and primarily located on the face and upper limbs. The direct agglutination test outperformed the indirect method in sensitivity and specificity, proving its effectiveness for diagnosing leishmaniasis.
References
[1] Savoia, D.; “Recent updates and perspectives on leishmaniasis” Journal of infection in developing countries vol. 9, (6): 588-596, 2015,
[2] World Health Organization. First WHO report on neglected tropical diseases 2010: working to overcome the global impact of neglected tropical diseases. 2010.
[3] González, C.; Wang, O.; Strutz, S. E; González-Salazar, C.; Sánchez-Cordero, V.; Sarkar, S.; “Climate change and risk of leishmaniasis in north america: predictions from ecological niche models of vector and reservoir species” PLoS Negl. Trop. Dis., 4,1, 2010,
[4] Alawieh, A.; Musharrafieh, U.; Jaber, A.; Berry, A.; Ghosn, N.; Bizri, A. R.; “Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak” IJID, 29: 115-119, 2014.
[5] Curtin, J. M.; Aronson, N. E.; “Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity” Microorganisms, 9 (3) 578, 2021.
[6] Lockard, R. D.; Wilson, M. E.; Rodríguez, N. E.; “Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species” J Immunol Res, 2019 4103819, 2019,
[7] Choi, H.; Jain, S.; Ruiz Postigo, J.; Borisch, B.; Dagne, D.; ''The global procurement landscape of leishmaniasis medicines''. PLoS Negl. Trop. Dis., 15, 2021.
[8] Olías-Molero, A. I.; de la Fuente, C.; Cuquerella, M.; Torrado, J. J.; Alunda, J. M.; ''Antileishmanial Drug Discovery and Development: Time to Reset the Model?'' Microorganisms, 9(12), 2021.
[9] Scarpini, S.; Dondi, A.; Totaro, C.; Biagi, C.; Melchionda, F.; Zama, D.; Pierantoni, L.; Gennari, M.; Campagna, C.; Prete, A.; Lanari, M.; ''Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics'' Microorganisms, 10(10), 1887, 2022.
[10] Mcgwire, B. S.; Satoskar, A. R.;''Leishmaniasis: Clinical syndromes and treatment'' Qjm, 107(1): 7–14, 2014.
[11] Khanjani, N.; González, U.; Khamesipour, A.; Aguilar, C. M.; Rangel, E. F.; Garcia, L.; Fernandez, E.; Momen, H.; Grimaldi Filho, G.; De Vargas, Z.; ''A Meta-Analysis of Vaccines for Preventing Cutaneous Leishmaniasis'' J Vac Vac Stud,1(1): 19–28, 2020.
[12] Russell, E.; Douglas, A.; Van, S; Caci, J. A.; Dennett, B. T.; Jennings, R. C.; John, P. G.; Hopkins, J. L.; ''Impact of Phlebotomine Sand Flies on United State Military Operations at Tallil Air Base, Iraq: 6. Evaluation of Insecticides for the Control of Sand Flies'' J Med Entomol, 48(3):584-599, 2011.
[13] Jacobson, R. L.; ''Leishmaniasis in an era of conflict in the Middle East'' Vect. Borne Zoonot. Dis., 11: 247–258 ,2011.
[14] Ready, P. D.; ''Biology of Phlebotomine Sand Flies as Vectors of Disease Agents'' Annual Rev. Entomol. 58: 227–250, 2013.
[15] Lesho, E. P.; Neafie, R.; Wortmann, G.; Aronson, N; ''Non healing skin lesions in a sailor and a journalist returning from Iraq'' Clevel. Clin. J. Med. 72: 93–106, 2005.
[16] AlSamarai, A. M.; AlObaidi, H. S.; ''Cutaneous leishmaniasis in Iraq'' J Infect. Dev. Count., 3(2): 123–129, 2009
[17] Bailey, M. S.; Lockwood, D. N. J.; ''Cutaneous leishmaniasis'' Clinics in Dermatology, 25(2): 203–211, 2007.
[18] Steverding, D.; ''The history of leishmaniasis. Parasites & vectors'' 10(1), 82, 2017. https://doi.org/10.1186/s13071-017-2028-5
[19] Maxfield, L.; Jonathan S. C.; “Leishmaniasis.” StatPearls, StatPearls Publishing, 2023.
[20] Ovalle-Bracho, C.; Londoño-Barbosa, D.; Salgado-Almario, J.; González, C.; “Evaluating the spatial distribution of Leishmania parasites in Colombia from clinical samples and human isolates (1999 to 2016)” PloS one., 14,3, 2019,
[21] Aronson, N.; Herwaldt, B. L.; Libman, M.; Pearson, R.; Lopez-Velez, R.; Weina, P.; Carvalho, E. M.; Ephros, M.; Jeronimo, S.; Magill, A.; ''Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)'' Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 63(12): 202–264, 2016.
[22] Aronson, N.E.; Joya, C.A.; ''Cutaneous leishmaniasis: updates in diagnosis and management'' Infect Dis Clin North Am., 33(1):101–117, 2019.
[23] Burza, S.; Croft, S.L.; Boelaert, M.; ''Leishmaniasis'' Lancet., 392(10151):951–970, 2018
[24] Pradhan, S.; Schwartz, R.A.; Patil, A.; Grabbe, S.; Goldust, M.; ''Treatment options for leishmaniasis'' Clinical and Experimental Dermatology, 47: 516–521, 2022
[25] Saab, M.; El Hage, H.; Charafeddine, K.; Habib, R. H.; Khalifeh, I.; ''Diagnosis of cutaneous leishmaniasis: why punch when you can scrape?'' The American journal of tropical medicine and hygiene, 92(3): 518–522, 2015.
[26] Boelaert, M.; Verdonck, K.; Menten, J.; Sunyoto, T.; van Griensven, J.; Chappuis, F.; Rijal, S.; ''Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease'' The Cochrane database Syst Rev., 6, 2014
[27] Bajalan, M.; Al-Jaf, S.; Niranji, S.; Abdulkareem, D.; Al- Kayali, K.; Kato, H.; ''An outbreak of Leishmania major from an endemic to a non-endemic region posed a public health threat in Iraq from 2014-2017: Epidemiological, molecular and phylogenetic studies''PLoS Negl Trop Dis., 12, 2018.
[28] Zhao, Y.; Riyadh, L.; Amy, H.; Abraham, D.F.; ''The epidemiology of 32 selected communicable diseases in Iraq, 2004–2016'' Int J Infect Dis., 89: 102-109, 2019.
[29] Abdon, F. M.; Abbadi, O. S.; Saad, A. A.; ''Testing the prevalence of Leishmania donovani DNA in the Blood of Sudanese blood donors'' Infect. Dis. Trop. Med., 6, 2020.
[30] Mancy, A.; Awad, K.M.; Abd-Al-Majeed, T.; Jameel, N.F.; ''The epidemiology of cutaneous leishmaniasis in Al-Ramadi, Iraq'' Our Dermatol Online, 13(4):402-407, 2022.
[31] Mohammed, O. M.; epidemiological and demographic analysis of cutaneous leishmaniasis cases in Ramadi. european journal of modern medicine and practice, 4(8): 338–347, 2024.
[32] Al-Obaidi, M.; Ali, H.; ''Evaluation of the Surveillance and Epidemiological Aspects of Cutaneous Leishmaniasis in Babylon Province, Iraq'' Iraqi J Sci, 62( 3), 793-800, 2021
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hadeer F. Hamoodi, Muna B. Aldeen, Nada M. Elewi, Sally H. Abdulkhaliq
This work is licensed under a Creative Commons Attribution 4.0 International License.
.jpg)
